Person: BEKTAY, MUHAMMED YUNUS
Loading...
Status
Kurumdan Ayrılmıştır.
Organizational Units
5 results
Search Results
Now showing 1 - 5 of 5
Publication Open Access Insight into Turkish Community Pharmacists’ Services in the First Wave of the COVID-19 Pandemic(2021-06-01T00:00:00Z) Okuyan, Betül; İzzettin, Fikret Vehbi; BEKTAY, MUHAMMED YUNUS; İZZETTİN, FIKRET VEHBIPublication Open Access Time to change to improve health: clinical pharmacy and pharmaceutical care education in Turkey(2020-05-01T00:00:00Z) Bektay, Muhammed Yunus; Sancar, Mesut; Al-Ezzı, Saad Ahmed Ali; BEKTAY, MUHAMMED YUNUS; AL-EZZI, SAAD AHMED ALİ; İZZETTİN, FIKRET VEHBIThe practice of clinical pharmacy had a positive impact on the profession by giving pharmacists more job opportunities. Moreover, the pharmacy began to gain the status it deserved, which was lost many years ago. In this paper, we aimed to give a brief explanation of the clinical pharmacy philosophy and definition of pharmaceutical care. What are the general and specific roles of clinical pharmacists in the modern world healthcare system? Also, how to implement clinical pharmacy in education to obtain competent pharmacists. We shared our observation and experience, specifically on the progress of implementation of clinical pharmacy education in Turkey. The stepwise method has been successfully followed in the implementation of clinical pharmacy education in Turkey. In the undergraduate program, the first step taken was the addition of clinical courses, such as the role of clinical pharmacy, patient education, etc. and practical hospital rounds (internal medicine, pediatrics, and surgery). The post-graduate program, such as master (MSc) and doctoral (Ph.D.) degrees, also offered to prepare clinically oriented pharmacy academicians. The continuous education programs were structured to implement clinical pharmacy idea for the pharmacists in practice. In conclusion, the stepwise approach significantly smoothed the transition from the product-oriented to the patient-oriented pharmacy education. Moreover, the adoption of the skills education system to educate pharmacists needs to review the policy regularly and gradually change it accordingly.Publication Metadata only Treatment of coronavirus disease 2019: a comprehensive review(2020-11-01T00:00:00Z) Sosyal, Damla; Özmen, Özge; Bektay, Muhammed Yunus; İzzettin, Fikret Vehbi; SOSYAL, DAMLA; ÖZMEN, ÖZGE; BEKTAY, MUHAMMED YUNUS; İZZETTİN, FIKRET VEHBIThe new type of Coronavirus (SARS-CoV-2) is a highly contagious pathogen that causes severe acute respiratory syndrome and can be transmitted from human to human. COVID-19, which has been declared as a pandemic by the world health organization and is infected with more than 50 million people, is also responsible for the death of more than 1 million people. There is no sufficient data from randomized clinical trials that any potential treatment improves outcomes in COVID-19 patients. Chloroquine and hydroxychloroquine, antivirals such as favipiravir, lopinavir/ritonavir, immunomodulatory agents tocilizumab, siltuximab, and sarilumab, and anti-inflammatory drugs such as steroids are used for the treatment of COVID-19. Repurposing drugs can provide new treatment options faster than discovering new drugs due to the known safety profiles of existing drugs. On the other hand, there are new drug and vaccine trials for COVID-19. Many researchers, governmental or non-governmental institutions having clinical trials for COVID-19 drugs and vaccines. In this comprehensive review, we investigate the clinical features, management, and treatment of COVID-19 and possible adverse effects and important information related to drugs used for COVID-19. For future preparedness and readiness, new laws and legislations should be constituted. Besides, emergency teams and budgets should be prepared as well.Publication Metadata only Attitudes of Medicine, Pharmacy and Dentistry Students about Psychostimulant Use to Enhance Cognition(2021-07-01T00:00:00Z) Sümbül Şekerci, Betül; Bildik, Özlem; Bektay, Muhammed Yunus; İzzettin, Fikret Vehbi; SÜMBÜL ŞEKERCİ, BETÜL; BİLDİK, ÖZLEM; BEKTAY, MUHAMMED YUNUS; İZZETTİN, FIKRET VEHBIPublication Metadata only Comparison of different decision support software programs in perspective of potential drug–drug interactions in the oncology clinic(2022-05-01T00:00:00Z) Bektay, Muhammed Yunus; Şeker, Zehra; Eke, Hatice Kubra; Türk, Hacı Mehmet; İzzettin, Fikret Vehbi; BEKTAY, MUHAMMED YUNUS; ŞEKER, ZEHRA; TÜRK, HACI MEHMET; İZZETTİN, FIKRET VEHBI